{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:18:32Z","timestamp":1768911512524,"version":"3.49.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Variability in methotrexate (MTX) efficacy represents a barrier to early and effective disease control in the treatment of juvenile idiopathic arthritis (JIA). This work seeks to understand the impact of MTX on the plasma metabolome and to identify metabolic biomarkers of MTX efficacy in a prospective cohort of children with JIA. Plasma samples from a cohort of children with JIA (<jats:italic>n<\/jats:italic> = 30) collected prior to the initiation of MTX and after 3\u00a0months of therapy were analyzed using a semi-targeted global metabolomic platform detecting 673 metabolites across a diversity of biochemical classes. Disease activity was measured using the 71-joint count juvenile arthritis disease activity score (JADAS-71) and clinical response to MTX was based on achievement of ACR Pedi 70 response. Metabolomic analysis identified 50 metabolites from diverse biochemical classes that were altered following the initiation of MTX (<jats:italic>p<\/jats:italic> &amp;lt; 0.05) with 15 metabolites reaching a false-discovery rate adjusted p-value (q-value) of less than 0.05. Enrichment analysis identified a class-wide reduction in unsaturated triglycerides following initiation of MTX (q = 0.0009). Twelve of the identified metabolites were significantly associated with disease activity by JADAS-71. Reductions in three metabolites were found to be associated with clinical response by ACR Pedi 70 response criteria and represented several microbiota and exogenously derived metabolites including: dehydrocholic acid, biotin, and 4-picoline. These findings support diverse metabolic changes following initiation of MTX in children with JIA and identify metabolites associated with microbial metabolism and exogenous sources associated with MTX efficacy.<\/jats:p>","DOI":"10.3389\/fphar.2021.768599","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:17:03Z","timestamp":1639048623000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis"],"prefix":"10.3389","volume":"12","author":[{"given":"Ryan Sol","family":"Funk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0167-4501(98)80029-0","article-title":"Flavornet: A Database of Aroma Compounds Based on Odor Potency in Natural Products","volume":"40","author":"Arn","year":"1998","journal-title":"Dev. Food Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/art.41622","article-title":"The Pretreatment Gut Microbiome Is Associated with Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis","volume":"73","author":"Artacho","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1038\/s41598-017-15231-w","article-title":"Chemical Similarity Enrichment Analysis (ChemRICH) as Alternative to Biochemical Pathway Mapping for Metabolomic Datasets","volume":"7","author":"Barupal","year":"2017","journal-title":"Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2105-13-99","article-title":"MetaMapp: Mapping and Visualizing Metabolomic Data by Integrating Information from Biochemical Pathways and Chemical and Mass Spectral Similarity","volume":"13","author":"Barupal","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/clpt.2011.293","article-title":"Optimization of Pediatric Rheumatology Therapeutics","volume":"91","author":"Becker","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics Enables Precision Medicine: \"A White Paper, Community Perspective\"Metabolomics Enables Precision Medicine: \"A White Paper, Community Perspective","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1021\/acs.analchem.5b04491","article-title":"Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics","volume":"88","author":"Cajka","year":"2016","journal-title":"Anal. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/annrheumdis-2013-203723","article-title":"Methotrexate Polyglutamates in Erythrocytes Are Associated with Lower Disease Activity in Juvenile Idiopathic Arthritis Patients","volume":"74","author":"\u0106alasan","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Ravelli, A., and Paediatric Rheumatology International Trials, ODevelopment and Validation of a Composite Disease Activity Score for Juvenile Idiopathic Arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B10","first-page":"S157","article-title":"Toward a Treat-To-Target Approach in the Management of Juvenile Idiopathic Arthritis","volume":"30","author":"Consolaro","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its Mechanisms of Action in Inflammatory Arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/rheumatology\/keh401","article-title":"Adenosine and Methotrexate Polyglutamate Concentrations in Patients with Juvenile Arthritis","volume":"44","author":"Dolezalov\u00e1","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-94-010-0448-0_11","article-title":"Metabolomics--the Link between Genotypes and Phenotypes","volume":"48","author":"Fiehn","year":"2002","journal-title":"Plant Mol. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/0471142727.mb3004s114","article-title":"Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling","volume":"114","author":"Fiehn","year":"2016","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/23808993.2016.1133234","article-title":"Disease Modifying Anti-rheumatic Drugs in Juvenile Idiopathic Arthritis: Striving for Individualized Therapy","volume":"1","author":"Funk","year":"2016","journal-title":"Expert Rev. Precision Med. Drug Develop."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1002\/art.38865","article-title":"Folate Depletion and Increased Glutamation in Juvenile Idiopathic Arthritis Patients Treated with Methotrexate","volume":"66","author":"Funk","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cts.12694","article-title":"Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate In Vitro","volume":"13","author":"Funk","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10067-011-1848-5","article-title":"Omega-3 Fatty Acids in Juvenile Idiopathic Arthritis: Effect on Cytokines (IL-1 and TNF-\u03b1), Disease Activity and Response Criteria","volume":"31","author":"Gheita","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in Resistant Juvenile Rheumatoid Arthritis. Results of the U.S.A.-U.S.S.R. Double-Blind, Placebo-Controlled Trial. The Pediatric Rheumatology Collaborative Study Group and the Cooperative Children's Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202:AID-ART3>3.0.CO;2-R","article-title":"Preliminary Definition of Improvement in Juvenile Arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s10067-017-3586-9","article-title":"The Profile of Polyunsaturated Fatty Acids in Juvenile Idiopathic Arthritis and Association with Disease Activity","volume":"36","author":"Gorczyca","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/jpm10040271","article-title":"Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis","volume":"10","author":"Gosselt","year":"2020","journal-title":"J. Pers Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2016.1","article-title":"Metabolomics in Rheumatic Diseases: Desperately Seeking Biomarkers","volume":"12","author":"Guma","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/metabo10050213","article-title":"Impact of Pre-blood Collection Factors on Plasma Metabolomic Profiles","volume":"10","author":"Hardikar","year":"2020","journal-title":"Metabolites"},{"key":"B25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s0022-3476(89)80148-9","article-title":"Dyslipoproteinemia in Juvenile Rheumatoid Arthritis","volume":"114","author":"Ilowite","year":"1989","journal-title":"J. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1021\/pr400415a","article-title":"Serum Metabolic Signatures of Four Types of Human Arthritis","volume":"12","author":"Jiang","year":"2013","journal-title":"J. Proteome Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/art.37921","article-title":"Metabolic Profiling Predicts Response to Anti-tumor Necrosis Factor \u03b1 Therapy in Patients with Rheumatoid Arthritis","volume":"65","author":"Kapoor","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0205707","DOI":"10.1371\/journal.pone.0205707","article-title":"Accurate Measurement of Endogenous Adenosine in Human Blood","volume":"13","author":"L\u00f6fgren","year":"2018","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.1038\/s41598-021-86729-7","article-title":"Prediction of Response of Methotrexate in Patients with Rheumatoid Arthritis Using Serum Lipidomics","volume":"11","author":"Maciejewski","year":"2021","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1017\/S0007114512001560","article-title":"Influence of marine N-3 Polyunsaturated Fatty Acids on Immune Function and a Systematic Review of Their Effects on Clinical Outcomes in Rheumatoid Arthritis","volume":"107","author":"Miles","year":"2012","journal-title":"Br. J. Nutr."},{"key":"B31","first-page":"163","article-title":"Adenosine Deaminase and C-Reactive Protein in Diagnosing and Monitoring of Rheumatoid Arthritis","volume":"8","author":"Nalesnik","year":"2011","journal-title":"Med. Glas (Zenica)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.3390\/ijms19092491","article-title":"Electrochemical Oxidation of Primary Bile Acids: A Tool for Simulating Their Oxidative Metabolism?","volume":"19","author":"Navarro Suarez","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.chom.2020.12.008","article-title":"Methotrexate Impacts Conserved Pathways in Diverse Human Gut Bacteria Leading to Decreased Host Immune Activation","volume":"29","author":"Nayak","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B34","first-page":"390","article-title":"International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: Second Revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut Microbiota Functions: Metabolism of Nutrients and Other Food Components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A Randomized Trial of Parenteral Methotrexate Comparing an Intermediate Dose with a Higher Dose in Children with Juvenile Idiopathic Arthritis Who Failed to Respond to Standard Doses of Methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41584-020-0395-3","article-title":"Pharmacomicrobiomics in Inflammatory Arthritis: Gut Microbiome as Modulator of Therapeutic Response","volume":"16","author":"Scher","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of Gut Microbiota with Bile Acid Metabolism and its Influence on Disease States","volume":"101","author":"Staley","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/1529-0131(199902)42:2<373:AID-ANR21>3.0.CO;2-3","article-title":"Association of the Inflammatory State in Active Juvenile Rheumatoid Arthritis with Hypo-High-Density Lipoproteinemia and Reduced Lipoprotein-Associated Platelet-Activating Factor Acetylhydrolase Activity","volume":"42","author":"Tselepis","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/ard.2008.092668","article-title":"Optimal Dosage and Route of Administration of Methotrexate in Rheumatoid Arthritis: a Systematic Review of the Literature","volume":"68","author":"Visser","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2119\/molmed.2011.00048","article-title":"Low-dose Methotrexate Inhibits Methionine S-Adenosyltransferase In Vitro and In Vivo","volume":"18","author":"Wang","year":"2012","journal-title":"Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3892\/etm.2012.567","article-title":"(1)H NMR-Based Metabolomic Analysis for Identifying Serum Biomarkers to Evaluate Methotrexate Treatment in Patients with Early Rheumatoid Arthritis","volume":"4","author":"Wang","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"B43","first-page":"49","article-title":"Role of Dyslipidemia in Accelerating Inflammation, Autoimmunity, and Atherosclerosis in Systemic Lupus Erythematosus and Other Autoimmune Diseases","volume":"30","author":"Wang","year":"2020","journal-title":"Discov. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2021.02.016","article-title":"Methotrexate Works Remotely, from the Gut","volume":"29","author":"Wu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cpbi.11","article-title":"Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis","volume":"55","author":"Xia","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0--making Metabolomics More Meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.38021","article-title":"The Impact of Inflammation on Metabolomic Profiles in Patients with Arthritis","volume":"65","author":"Young","year":"2013","journal-title":"Arthritis Rheum."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.768599\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:17:12Z","timestamp":1639048632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.768599\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":47,"alternative-id":["10.3389\/fphar.2021.768599"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.768599","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"article-number":"768599"}}